Yves Sagot

Biography

 Dr Yves Sagot, born in 1964, is a French citizen. Yves received his PhD in Neurobiology at the University Paul Sabatier (Toulouse, France) for his work on factors regulating axonal regeneration. He did his postdoctoral studies at the University Medical Center (CMU, University of Geneva) on motoneuron diseases. In 1999 he joined Serono international SA, to work on neurodegenerative and neuroinflammatory diseases as group leader and technological platform leader. In 2001 he received the Serono CEO award for his team building spirit and accomplished work. He had the privilege to bring a biologics towards phase I for an autoimmune disease of the peripheral nervous system. Following Merck take-over in 2007, Dr Yves Sagot activities focused on therapeutic target validation for Alzheimer and Parkinson’s diseases, through internal and external partnerships with public or privates institutions. Pairs acknowledged his work through the Merck Serono Reward and Recognition award 2008 for innovation and target support. He is one of the founders of Relief Therapeutics SA acting as managing partner and CSO. In 2014, he completed his formation by obtaining a Certificate of Advance Studies in Management of Biotech, Medtech and Pharma Ventures at the EPFL (Swiss Federal Institute of Technology, Lausanne, Switzerland). Until recently, he maintained his consulting activities as expert on neurodegenerative diseases and target validation for private and public foundations.

Research Interest

 Neurobiology